Press Release
[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate
development of the treatment
development of the treatment
Writer|
Views |
Date|
| Prev | [Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results 2022-05-26 |
|---|---|
| Next | COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020 2020-12-21 |